NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 26 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11 | +37.5% | 36,297 | -1.7% | 0.00% | – |
| Q4 2022 | $8 | -100.0% | 36,936 | +17.3% | 0.00% | – |
| Q1 2022 | $25,000 | -44.4% | 31,500 | -26.7% | 0.00% | – |
| Q4 2021 | $45,000 | +4.7% | 42,984 | +68.6% | 0.00% | – |
| Q3 2021 | $43,000 | -25.9% | 25,500 | -12.1% | 0.00% | – |
| Q1 2021 | $58,000 | -40.2% | 29,019 | -40.0% | 0.00% | – |
| Q4 2020 | $97,000 | +136.6% | 48,347 | +238.1% | 0.00% | – |
| Q3 2020 | $41,000 | -69.9% | 14,300 | -60.1% | 0.00% | – |
| Q2 2020 | $136,000 | +403.7% | 35,805 | +6.8% | 0.00% | – |
| Q1 2020 | $27,000 | -32.5% | 33,526 | +3.2% | 0.00% | – |
| Q4 2019 | $40,000 | – | 32,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allred Capital Management, LLC | 36,838 | $26,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 102,440 | $74,000 | 0.00% |
| PDS Planning, Inc | 10,565 | $8,000 | 0.00% |
| UBS Group AG | 105 | $0 | 0.00% |
| Parallel Advisors, LLC | 350 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,722 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,954 | $3,000 | 0.00% |
| NORTHERN TRUST CORP | 39,414 | $28,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 227,452 | $164,000 | 0.00% |